Botox is a widely used injectable neuromodulator in aesthetic dermatology that temporarily reduces facial wrinkles by relaxing targeted muscles responsible for repeated skin folding. The treatment works by blocking nerve signals that cause muscle contraction, allowing the overlying skin to appear smoother while maintaining natural facial movement. Several FDA-approved formulations exist, including Botox Cosmetic, Dysport, Xeomin, Jeuveau, and Daxxify, each designed to treat dynamic expression lines such as forehead creases, frown lines, and crow’s feet.

A typical Botox procedure begins with a clinical consultation and facial assessment, followed by precise injections placed into selected facial muscles during a short in-office session that usually takes about 10–20 minutes. Results begin to appear within a few days and commonly last about three to four months, although repeated treatments may extend the duration closer to four to six months. Proper preparation before treatment and simple post-procedure precautions help support optimal results and minimize temporary side effects such as mild redness or bruising.

Botox remains a minimally invasive cosmetic treatment with adjustable dosing, making it suitable for adults with dynamic wrinkles caused by facial muscle movement. Pricing varies depending on the treatment area, number of units required, and injector expertise, particularly in locations such as New York City where cost often reflects dose and treatment complexity. Understanding the mechanism, procedure, expected results, benefits, risks, and candidate suitability helps patients make informed decisions about Botox treatment.

What is botox?

Botox is a purified injectable form of botulinum toxin type A used in aesthetic dermatology to reduce facial lines and wrinkles. Clinicians place small doses into targeted facial muscles during a brief procedure performed in a clinical setting. Treatment focuses on expression-related lines, including forehead creases, glabellar folds, and crow’s feet, with cost varying by treatment area, dose units, and clinic expertise.

After injection, botulinum toxin blocks acetylcholine release at the neuromuscular junction within superficial facial muscles that influence skin movement. This interruption reduces repetitive muscle contraction that forms dynamic wrinkles. Controlled clinical evaluation reports a 75–90% reduction in glabellar line severity within treated participants according to the Phase III Clinical Trials of OnabotulinumtoxinA for Glabellar Lines.

Following treatment, the overlying skin appears smoother and expression lines soften within several days, with visible improvement lasting about three to four months in many patients. Results vary with muscle activity, dose distribution, and skin condition. Botox does not treat volume loss, deep structural folds, or skin texture disorders, and repeated sessions remain necessary to maintain wrinkle reduction.

How does botox work?

Botox works by temporarily reducing the activity of specific facial muscles that create expression lines on the skin. The injection contains a purified form of botulinum toxin type A, which dermatologists place in very small doses into targeted muscles beneath the skin. These muscles normally contract when you smile, frown, or raise your eyebrows, repeatedly folding the skin and forming wrinkles over time.

After injection, the toxin blocks the release of acetylcholine, a neurotransmitter that signals muscles to contract. When this signal is interrupted, the treated muscle relaxes and its movement decreases. With less repeated folding of the skin above the muscle, dynamic wrinkles such as forehead lines, frown lines between the eyebrows, and crow’s feet gradually soften and become less visible.

The skin itself is not directly changed by the toxin; instead, the reduced muscle activity allows the skin surface to remain smoother during facial expressions. Effects usually begin within 3–5 days, reach peak improvement in about 10–14 days, and typically last 3–4 months before muscle activity slowly returns.

What are the types of botox?

• Botox Cosmetic (onabotulinumtoxinA)

Botox Cosmetic (onabotulinumtoxinA) is an injectable neuromodulator derived from botulinum toxin type A that reduces dynamic facial wrinkles by temporarily relaxing targeted facial muscles. Clinicians often use this formulation for forehead lines, glabellar lines, and crow’s feet when precise dosing and well-established clinical protocols are preferred. Controlled trials report significant improvement in glabellar line severity among treated patients according to Phase III clinical studies of onabotulinumtoxinA.

• Dysport (abobotulinumtoxinA)

Dysport (abobotulinumtoxinA) is a botulinum toxin type A injectable designed to reduce facial wrinkles through temporary muscle relaxation. Practitioners may select Dysport for broader treatment areas such as the forehead because the formulation shows wider diffusion across injected muscle fibers. Clinical evaluation demonstrates improvement in moderate to severe glabellar lines in treated participants according to randomized controlled trials of abobotulinumtoxinA.

• Xeomin (incobotulinumtoxinA)

Xeomin (incobotulinumtoxinA) is a purified botulinum toxin type A injection formulated without accessory proteins and used to reduce expression-related facial wrinkles. Clinicians may choose Xeomin when a simplified formulation is preferred for patients with prior exposure to botulinum toxin treatments. Clinical guidelines from the American Society for Dermatologic Surgery recognize incobotulinumtoxinA as an approved neuromodulator for glabellar line treatment.

• Jeuveau (prabotulinumtoxinA)

Jeuveau (prabotulinumtoxinA) is a botulinum toxin type A injectable developed specifically for aesthetic treatment of facial wrinkles. Dermatologists often use Jeuveau for glabellar frown lines in adult patients seeking cosmetic wrinkle reduction with a formulation designed for aesthetic practice. Clinical trials report measurable improvement in glabellar line severity among treated participants according to Phase III trials evaluating prabotulinumtoxinA.

• Daxxify (daxibotulinumtoxinA-lanm)

Daxxify (daxibotulinumtoxinA-lanm) is a long-acting botulinum toxin type A injectable used to treat facial expression lines through temporary muscle relaxation. Practitioners may consider this option when longer treatment duration is desired compared with conventional neuromodulators. Clinical studies report wrinkle reduction lasting up to six months in treated patients according to the SAKURA Phase III clinical trials of daxibotulinumtoxinA-lanm.

What is the procedure of getting botox?

Step 1: Consultation with Dr. Syra Hanif

The procedure begins with a consultation with Dr. Syra Hanif, a board-certified physician who evaluates facial anatomy, skin movement, and medical history. During this step, treatment goals and targeted areas such as forehead lines, frown lines, or crow’s feet are identified to create a personalized injection plan.

Step 2: Facial assessment and treatment planning

Dr. Hanif observes how facial muscles move during expressions such as smiling or frowning. Based on this assessment, she determines the appropriate injection points and number of Botox units required for each treatment area.

Step 3: Skin preparation

The treatment area is cleansed to remove oil, makeup, and surface bacteria. This preparation step ensures accurate injection placement and maintains clinical hygiene before the procedure begins.

Step 4: Targeted Botox injections

Dr. Syra Hanif injects small amounts of Botox into selected facial muscles using a very fine needle. The injections are placed precisely in muscles responsible for dynamic wrinkles so that muscle activity reduces while maintaining natural facial movement.

Step 5: Short in-office procedure

The injection process usually takes about 10–20 minutes, making Botox a quick outpatient treatment that does not require surgery or anesthesia.

Step 6: Immediate post-treatment period

After the injections, patients can leave the clinic immediately. The procedure involves little to no downtime, allowing most individuals to return to normal activities soon after treatment.

Step 7: Early results

The injected neuromodulator gradually relaxes the targeted muscles. Visible improvement generally begins within 3–5 days as muscle contractions decrease.

Step 8: Full effect and duration

As muscle activity decreases, facial lines soften and the skin appears smoother. Results commonly last about 3–6 months, after which repeat treatment may be performed to maintain wrinkle reduction.

How long does botox last?

Botox typically lasts about 3 to 4 months before muscle activity gradually returns and expression lines begin to reappear. Individuals who receive Botox injections regularly may notice results lasting closer to 4 to 6 months, as repeated treatments can reduce the strength and contraction frequency of targeted facial muscles over time. 

The longevity of Botox results mainly depends on three factors: facial muscle activity, the body’s metabolic rate in breaking down the toxin, and the consistency of maintenance treatments, all of which influence how long the neuromodulator remains effective.

How should I prepare before my Botox appointment?

Before a Botox appointment, patients usually avoid blood-thinning medications or supplements such as aspirin, ibuprofen, fish oil, or vitamin E for several days if medically appropriate, because these can increase the chance of bruising. Arriving with a clean face without makeup helps the clinician assess the skin and prepare the treatment area properly.

Can multiple facial areas be treated in the same Botox session?

Yes. Botox injections can treat multiple facial areas during the same session when clinically appropriate. Common combinations include the forehead, glabellar frown lines, and crow’s feet, since these regions involve related facial muscles. Treating several areas together allows the injector to balance muscle activity across the upper face and maintain natural facial movement.

What should I avoid after Botox?

• Avoid lying down for at least 4 hours after the injections, as remaining upright helps prevent the product from shifting away from the targeted muscles.
• Avoid rubbing, massaging, or pressing the treated areas for 24 hours, because pressure on the skin can displace the injected Botox and affect how evenly it settles in the muscles.
• Avoid strenuous exercise for about 24 hours, since increased blood flow from intense physical activity may influence how the toxin distributes shortly after injection.
• Avoid alcohol for 24 hours, as alcohol can increase the likelihood of bruising around injection sites.
• Avoid excessive heat exposure, including saunas, steam rooms, hot tubs, or prolonged sun exposure for about 24 hours, because heat can increase circulation and may affect the early settling phase of the injections.
• Avoid cosmetic facial treatments for several days, such as facials, chemical peels, or laser treatments, since these procedures apply pressure or heat to the treated areas.
• Avoid wearing tight headgear or hats that press on the forehead area if injections were placed there, as constant pressure may interfere with the positioning of the product shortly after treatment.

What should you expect after getting botox treatment?

After getting Botox treatment, mild redness or slight swelling can appear at the injection sites and usually resolves within a few hours, while minor bruising may develop in some cases and fade over several days. Results do not appear immediately; muscle relaxation begins gradually, with visible softening of expression lines often noticeable within 3 to 5 days and the full cosmetic effect developing in about 10 to 14 days. Facial movement remains natural because only targeted muscles relax, and the effects are temporary, lasting around 3 to 4 months before muscle activity slowly returns.

What are the benefits of botox?

• Reduces dynamic facial wrinkles, including forehead lines, frown lines, and crow’s feet by relaxing targeted facial muscles.
• Softens repeated expression lines, which helps the skin appear smoother when facial muscles contract less frequently.
• Provides a minimally invasive treatment, since the procedure involves small injections without surgery or significant recovery time.
• Produces gradual and natural-looking results, allowing facial expressions to remain present while reducing wrinkle depth.
• Short treatment time, as most Botox sessions are completed within about 10–20 minutes in a clinical setting.
• Temporary and adjustable results, which allow treatment plans to be modified in future sessions based on patient response and aesthetic goals.

Are there any side effects or risks of getting botox?

• Mild redness or swelling at injection sites, which usually resolves within several hours after treatment.
• Temporary bruising, which may appear around the injection area and typically fades within a few days.
• Headache or mild discomfort, occasionally reported after injections in the forehead region.
• Temporary eyelid or eyebrow drooping, which can occur if the toxin affects nearby muscles but usually resolves as the treatment wears off.
• Uneven facial movement in rare cases, particularly if injections spread beyond the targeted muscles.
• Allergic reactions are uncommon, but symptoms such as rash or itching may occur in rare situations.

How much does botox cost?

Botox cost in New York City depends on several treatment-specific factors rather than a fixed universal price. Clinics usually calculate pricing per unit of botulinum toxin used or per treatment area, and the final cost reflects the number of units required for each facial muscle group. Areas with stronger or larger muscles, such as the masseter or neck bands, generally require more units and therefore higher treatment cost, while smaller areas like lip flip or bunny lines require fewer units. 

The experience of the injector, clinic location, treatment complexity, and total number of injection sites also influence the final price. Because Botox is a dose-based injectable treatment, the cost structure closely relates to muscle strength, wrinkle severity, and the number of units needed to achieve effective muscle relaxation.

Botox Treatment Area	Typical Units Used	Estimated Cost (NYC)
Forehead Lines	10–20 units	$150 – $400
Glabellar Lines (Frown Lines / “11s”)	15–25 units	$200 – $500
Crow’s Feet (both sides)	12–24 units	$180 – $450
Brow Lift (Botox Brow Lift)	4–8 units	$100 – $200
Bunny Lines (Nose Wrinkles)	5–10 units	$75 – $175
Lip Flip (Upper Lip)	4–8 units	$80 – $200
Chin (Dimpled Chin / Mentalis)	6–10 units	$120 – $250
DAO / Downturned Mouth Corners	6–10 units	$120 – $250
Jawline / Masseter (Jaw Slimming)	40–80 units	$800 – $1,500
Neck Bands (Platysmal Bands)	25–50 units	$400 – $900
Full Upper Face (Forehead + Glabella + Crow’s Feet)	30–60 units	$500 – $1,200

Are you a good candidate for botox?

A good candidate for Botox is an adult with dynamic facial wrinkles caused by repeated muscle movement, such as forehead lines, frown lines, or crow’s feet, who seeks temporary wrinkle reduction through injectable treatment. Ideal candidates generally have moderate skin elasticity, realistic expectations, and no contraindications to botulinum toxin injections. In contrast, individuals with deep static wrinkles caused by skin laxity, certain neuromuscular conditions, active skin infections at injection sites, or pregnancy are usually not considered appropriate candidates for Botox treatment.

Can younger adults be candidates for Botox?

 Yes. Adults in their mid-20s to early-30s may receive Botox as a preventive treatment when early expression lines begin to appear. However, individuals without visible dynamic wrinkles or muscle-related lines may not benefit from treatment.

Are older adults good candidates for Botox?

Yes, when wrinkles are primarily caused by muscle movement rather than skin laxity. If wrinkles remain visible even when the face is at rest due to volume loss or skin thinning, Botox alone may not produce significant improvement.

Can someone with strong facial muscles receive Botox?

 Yes. Patients with strong or active facial muscles often respond well because Botox directly targets muscle contraction responsible for wrinkle formation. These individuals may require higher unit doses to achieve effective muscle relaxation.

Who should avoid Botox treatment?

People with neuromuscular disorders, allergies to botulinum toxin ingredients, infections near injection sites, or those who are pregnant or breastfeeding are generally advised not to receive Botox injections.

What is the history and evolution of botox?

Botox originates from research on botulinum toxin, a neurotoxin produced by the bacterium Clostridium botulinum. In the early twentieth century, scientists studied the toxin mainly to understand foodborne botulism. By the 1970s, ophthalmologist Dr. Alan B. Scott began investigating purified botulinum toxin as a treatment for eye muscle disorders, particularly strabismus, because the toxin temporarily relaxes overactive muscles.

Clinical development progressed during the 1980s when the purified toxin, initially called Oculinum, received approval in 1989 from the U.S. Food and Drug Administration (FDA) to treat strabismus and blepharospasm. In 1991, pharmaceutical company Allergan acquired the product and later renamed it Botox. During the 1990s, physicians observed that patients treated around the eyes for medical conditions also experienced visible reduction in facial wrinkles, which led to research on cosmetic applications.

In 2002, the FDA approved Botox Cosmetic (onabotulinumtoxinA) for the treatment of moderate to severe glabellar lines between the eyebrows, marking the beginning of widespread aesthetic use. Over the following years, additional neuromodulators such as Dysport (2009), Xeomin (2011), Jeuveau (2019), and Daxxify (2022) were introduced, expanding available formulations of botulinum toxin type A.

Today, Botox represents a widely used neuromodulator in dermatology and aesthetic medicine, applied for both cosmetic and medical indications. Cosmetic treatments focus on reducing dynamic wrinkles by temporarily relaxing targeted facial muscles, while medical uses include treatment of migraines, muscle spasticity, and excessive sweating. This evolution reflects a shift from a toxin studied for disease to a controlled therapeutic agent used in modern clinical practice.